Dr. Amy Kathryn Brandon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Unit 8500 Box 7016, Dpo, AE 09642 Phone: 346-479-88599 |
News Archive
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has received its first purchase order for DAVANAT from PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. Pro-Pharmaceuticals has received a purchase order for $200,000 which will be the upfront payment for this first shipment of DAVANAT.
A study of patients seen at two primary care practices at Massachusetts General Hospital has identified specific unmet socioeconomic needs that can interfere with the quality of care patients receive.
IgA nephropathy (IgAN) is a chronic kidney disease occurring in young adults and is one of the most common reasons for kidney transplantation in this age group.
The health implications of physical inactivity are truly a global issue with physical inactivity responsible for up to 8% of non-communicable diseases and deaths across the world, finds research published online in British Journal of Sports Medicine.
A new study published online in The FASEB Journal reveals a novel gene involved in maintaining body weight. Specifically, the study suggests that GTRAP3-18 interacts with pro-opiomelanocortin (POMC) in the hypothalamus to regulate food intake and blood glucose levels.
› Verified 1 days ago